The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight loss drugs, as phramaceutical prices take centre stage in his administration's messaging around affordability ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Access to the drugs has been a consistent problem for patients because of their cost and insurance coverage has been spotty.

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices ...

Trump announced big discounts to popular weight loss drugs Wegovy and Zepbound (also available for Diabetes treatment under the brand names Ozempic and Mounjaro ...

El presidente Donald Trump presentó el jueves un acuerdo con las farmacéuticas Eli Lilly y Novo Nordisk para ampliar la ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to lower prices for their ...